Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NACDS names marketing head

This article was originally published in The Tan Sheet

Executive Summary

The National Association of Chain Drug Stores taps Christopher P. Krese senior VP marketing, communications and media relations, effective April 19, the organization says. Krese comes to NACDS with 14 years of experience in trade associations, congressional offices and public affairs; previously, he served as senior VP of industry affairs for the American Frozen Food Institute. "Chris is the best in the business when it comes to industry and association messaging, branding and positioning," NACDS President and CEO Steven C. Anderson said. Krese will report directly to Anderson. The appointment follows NACDS' April 4 announcement of a communications department overhaul (1"The Tan Sheet" April 9, 2007, p. 16)...

You may also be interested in...



People In Brief

Cargill hires support for Omega-3 foray: Cargill's new omega-3 ingredient "promises to be an innovative alternative to existing omega-3 products in the area of flavor," the company announces in a March 29 release. To support the product's launch and Cargill's entry into the fish oil market, the firm hired David Lewis as omega-3 product manager. Lewis has been business unit director for Lipid Nutrition in North America, responsible for its nutritional oil business. He brings "solid, specialty ingredient sales and marketing skills to our business," Cargill said. Lewis will report to David Henstrom, general manager, Europe, Middle East and Africa...

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100407

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel